Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics
Go back to Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics| EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) | Delayed: 27.46 +0.27 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.19 | 52 Week High | $21.25 | |||
| Open | $27.30 | 52 Week Low | $16.37 | |||
| Day High | $27.58 | P/E | N/A | |||
| Day Low | $27.24 | EPS | $0.00 | |||
| Volume | 8,587 | |||||
| Evotec Aktiengesellschaft American Depositary Share (AMEX: EVTCY) | Delayed: 22.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.96 | 52 Week High | $11.93 | |||
| Open | $22.96 | 52 Week Low | $6.56 | |||
| Day High | $22.96 | P/E | N/A | |||
| Day Low | $22.96 | EPS | $0.00 | |||
| Volume | 1,020,350 | |||||
